A Molecular Epidemiological Assessment of Extrapulmonary Tuberculosis in San Francisco

Clinical Infectious Diseases

Volumn 38, Issue 1, 2004, Pages 25-31

  Ong, Adrian ^a,b   Creasman, Jennifer ^a   Hopewell, Philip C ^a   Gonzalez, Leah C ^a   Wong, Maida ^c   Jasmer, Robert M ^a   Daley, Charles L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TUBERCULOUS PLEURISY; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGY, MOLECULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; SAN FRANCISCO; TUBERCULOSIS, PLEURAL; TUBERCULOSIS, PULMONARY;

EID: 0347683356     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/380448     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention (CDC). Reported tuberculosis in the United States, 2000. Atlanta: US Department of Health and Human Services, CDC, 2001.
2. Shafer RW, Kim DS, Weiss JP, Quale JM. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 1991; 70:384-97.
3. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148:1292-7.
4. Braun MM, Byers RH, Heyward WL, et al. Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States. Arch Intern Med 1990; 150:1913-6.
5. Rieder HL, Snider DE Jr, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis 1990; 141:347-51.
6. Weir MR, Thornton GF. Extrapulmonary tuberculosis: experience of a community hospital and review of the literature. Am J Med 1985; 79:467-78.
7. Farer LS, Lowell AM, Meador MP. Extrapulmonary tuberculosis in the United States. Am J Epidemiol 1979; 109:205-17.
8. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep 1997; 46(RR-10):1-55.
9. van Embden JD, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31:406-9.
10. Ross BC, Dwyer B. Rapid, simple method for typing isolates of Mycobacterium tuberculosis by using the polymerase chain reaction. J Clin Microbiol 1993; 31:329-34.
11. Chaves F, Yang Z, el Hajj H, et al. Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis. J Clin Microbiol 1996; 34:1118-23.
12. Jasmer RM, Hahn JA, Small PM, et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med 1999; 130:971-8.
13. Wallgren A. The time-table of tuberculosis. Tubercle 1948; 29:245-51.
14. Valdes L, Alvarez D, San Jose E, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med 1998; 158:2017-21.
15. Roper WH WJ. Primary serofibrinous pleural effusion in military personnel. AM Rev Tuberc 1955; 71:616-34.
16. Seibert AF, Haynes J Jr, Middleton R, Bass JB Jr. Tuberculous pleural effusion: twenty-year experience. Chest 1991; 99:883-6.
17. Epstein DM, Kline LR, Albelda SM, Miller WT. Tuberculous pleural effusions. Chest 1987; 91:106-9.
18. Moudgil H, Sridhar G, Leitch AG. Reactivation disease: the commonest form of tuberculous pleural effusion in Edinburgh, 1980-1991. Respir Med 1994; 88:301-4.
19. Antoniskis D, Amin K, Barnes PF. Pleuritis as a manifestation of re-activation tuberculosis. Am J Med 1990; 89:447-50.
20. Stead WW, Eichenholz A, Strauss HK. Operative and pathological findings in twenty-four patients with the syndrome of idiopathic pleurisy with effusion presumably tuberculosis. AM Rev Tuberc 1955; 71: 473-502.
21. Abrams WB, Small MJ. Current concepts of tuberculous pleurisy as derived from pleural biopsy studies. Scand J Respir Dis 1960; 38:60-5.
22. Allen JC, Apicella MA. Experimental pleural effusion as a manifestation of delayed hypersensitivity to tuberculin PPD. J Immunol 1968; 101: 481-7.
23. + T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 1989; 142:1114-9.
24. Ellner JJ, Barnes PF, Wallis RS, Modlin RL. The immunology of tuberculous pleurisy. Semin Respir Infect 1988; 3:335-42.
25. Rossi GA, Balbi B, Manca F. Tuberculous pleural effusions: evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection. Am Rev Respir Dis 1987; 136:575-9.
26. Sterling TR, Dorman SE, Chaisson RE, et al. Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses. Clin Infect Dis 2001; 33:976-82.
27. Stead WW. Genetics and resistance to tuberculosis: could resistance be enhanced by genetic engineering? Ann Intern Med 1992; 116:937-41.
28. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990; 322:422-7.